Guggenheim Lifts PT on AstraZeneca PLC (AZN) to 16,000 GBp From 15,500 GBp
AstraZeneca PLC (NASDAQ:AZN) is one of the most profitable blue chip stocks to invest in now.
Posts Tagged ‘NASDAQ:AZN’
12 Most Profitable Blue Chip Stocks to Invest In Now
On March 12, Stephen Parker, JPMorgan Private Bank co-head of global investment strategy, appeared on CNBC’s ‘Squawk Box’ to talk about the latest market trends and the ...
Morgan Stanley Sees Double-Digit EPS Growth for AstraZeneca PLC (AZN)
AstraZeneca PLC (NASDAQ:AZN) ranks among the 14 safe stocks to buy now for a starter stock portfolio.
Starter Stock Portfolio: 14 Safe Stocks to Buy Now
Global stock markets have continued to struggle as oil prices surged to their highest weekly spike in six years, with no signs of an imminent end to the Middle East conflict.
Why AstraZeneca PLC (AZN) is One of the Best Immunotherapy Stocks to Buy According to Hedge Funds
AstraZeneca PLC (NASDAQ:AZN) is one of the best immunotherapy stocks to buy according to hedge funds.
12 Best Immunotherapy Stocks to Buy According to Hedge Funds
On February 13, Matt Orton, Raymond James Investment Management's chief market strategist, appeared on CNBC’s ‘The Exchange’ to talk about the recent trends in equity markets...
Here’s What Lifted AstraZeneca PLC (AZN) in Q4
Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter “Carillon Eagle Growth & Income Fund”. A copy of the letter can...
Jim Cramer’s Game Plan: 19 Stocks in Focus
I don't usually start the game plan on Wednesday, but that's when we get the employment report this time, and it's kind of screwed up because of the government shutdown.
AstraZeneca PLC (NASDAQ:AZN) Announces Strategic Collaboration Agreement With CSPC Pharmaceuticals
AstraZeneca PLC (NASDAQ:AZN) is one of the best long term low volatility stocks to invest in.
Jim Cramer Shed Light on These 19 Stocks Recently
Jim Cramer, the host of Mad Money, on Friday highlighted a big development of the week, which was the nomination of Kevin Warsh to become the next chair of the Federal Reserve...
15 Best Long Term Low Volatility Stocks to Invest In
On January 26, Sherry Paul, Morgan Stanley senior portfolio manager, appeared on CNBC’s ‘Closing Bell’ to talk about the state of equity markets and whether more volatility...
AstraZeneca PLC (AZN)’s $15B China Expansion Fuels Long-Term Growth Outlook
AstraZeneca PLC (NASDAQ:AZN) is one of the best healthcare stocks to buy for 2026.
12 Best Healthcare Stocks to Buy for 2026
Artificial Intelligence has been the catalyst behind the blockbuster rally in equity markets over the past two years.
AstraZeneca PLC (AZN) Gains After Successful Saphnelo Trial
TheFly reported on January 6 that Barclays analyst James Gordon increased the price target on AZN to 16,500 GBp from 14,000 GBp.
Top 10 Oncology Stocks to Buy Now
The oncology market in the United States was estimated at $81.34 billion in 2025 and is expected to reach $211.78 billion by 2034 with a compound annual growth rate of 11.75...
AstraZeneca’s Subcutaneous Saphnelo Shows Significant Disease Reduction in Landmark Lupus Trial
AstraZeneca (NASDAQ:AZN) is one of the best future stocks to buy for the long term.
12 Best Future Stocks to Buy For the Long Term
On January 6, Dan Ives of Wedbush Securities joined 'Closing Bell' on CNBC to suggest that the tech bull market continues to play out.
What Makes AstraZeneca (AZN) a Strong Growing Company?
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth-quarter 2025 investor letter.
Berenberg Bank Remains Bullish on AstraZeneca PLC (AZN) – Here’s Why
AstraZeneca PLC (NASDAQ:AZN) is one of the best performing pharma stocks in 2025.
10 Best Performing Pharma Stocks in 2025
On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his bullish outlook on biopharma stocks in 2026 and...
10 Best Non-US Stocks to Buy According to Hedge Funds
On December 9, Michelle Gibley, Director of International Equity Research and Strategy at the Schwab Center for Financial Research, released her 2026 Outlook for International...
AstraZeneca (AZN) At the Center of Serious Analyst Attention
AstraZeneca PLC (NASDAQ:AZN), the British pharmaceutical company best known for its COVID-19 drug, was at the center of analyst action on December 9th after a report from TD Cowen...
13 Best ADR Stocks to Invest In
ADRs, or American Depository Receipts, are the US-listed securities of foreign firms that allow investors in America to buy and trade the shares within America.
Why is AstraZeneca PLC (AZN) One of the Best Pharma Stocks to Invest In?
AstraZeneca PLC (NASDAQ:AZN) is one of the best pharma stocks to invest in. AstraZeneca PLC (NASDAQ:AZN) received a rating update from JPMorgan on December 8, with the firm lifting...
11 Best Pharma Stocks to Invest In
CNBC reported on December 1 that the UK and US governments reached a deal on drug pricing.
AstraZeneca (AZN) Named One of BofA’s Top 25 Stocks for 2026
AstraZeneca PLC (NASDAQ:AZN) ranks among the Best Low Volatility Investments in December 2025.
10 Best Low Volatility Investments in December 2025
As the market finishes off a dull November, investors will be looking for signs of the broader economy's health in the weeks to come to help keep the US equity market steady.
AstraZeneca PLC (NASDAQ:AZN) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to AstraZeneca's 9 months and Q3 2025 webinar for investors and analysts.
J.P. Morgan Maintains a Buy Rating on AstraZeneca PLC (AZN), Sets a £140 PT
AstraZeneca PLC (NASDAQ:AZN) is one of the best long term low volatility stocks to buy right now. AstraZeneca PLC (NASDAQ:AZN) received a rating update from J.P.
AstraZeneca PLC (AZN): A Bull Case Theory
We came across a bullish thesis on AstraZeneca PLC on Disruptive analytics’s Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on AZN.
14 Best Long Term Low Volatility Stocks to Buy Right Now
Mike Wilson, Morgan Stanley CIO and chief U.S.
AstraZeneca (AZN) Jumps to All-Time High on Trump Drug Tariff Delay
AstraZeneca saw its share prices jump to a new all-time high on Wednesday, as investors cheered reports that President Donald Trump delayed the imposition of a 100-percent tariff...
AstraZeneca (AZN) Stock Target Raised as Goldman Sachs Sees $3.7 Billion Drug Potential
AstraZeneca PLC (NASDAQ:AZN) ranks among the most undervalued NASDAQ stocks to buy now.
14 Most Undervalued NASDAQ Stocks to Buy Now
On September 22, stocks surged to mark a third consecutive day of record-high closes, driven by hopes that the AI trade and additional Fed policy easing would boost the upward...
AstraZeneca PLC (AZN) Receives Tagrisso Boost in Lung Cancer Trials
AstraZeneca PLC (NASDAQ:AZN) is one of the best defensive stocks to buy, according to Steve Cohen.
10 Best Defensive Stocks to Buy According to Steve Cohen
Is it time to rebalance investment portfolios on equity valuations soaring with the S&P 500 powering through the 6,500 level? That’s the big question as uncertainty in the US...
AstraZeneca (AZN) Price Target Backed by Goldman After Baxdrostat Phase 3 Data
AstraZeneca PLC (NASDAQ:AZN) ranks among the best-performing European stocks to invest in.
9 Best Performing European Stocks to Invest In
With share values reaching their highest points since the global financial crisis, European banks have experienced a boom this year.
Goldman Sachs Remains Bullish on AstraZeneca (AZN)
AstraZeneca PLC (NASDAQ:AZN) is one of the best UK stocks to buy right now.
11 Best UK Stocks to Buy Right Now
He stated that the problem with the UK is two-fold: first, it has a bit more inflation in the near term than other advanced economies, so the market is pricing in some inflation...
AstraZeneca PLC (AZN) Oncology Sales Hit $12B in H1 2025
AstraZeneca PLC (NASDAQ:AZN), headquartered in Cambridge, England, is a leading global biopharmaceutical company with a major role in the oncology sector.
11 Best Cancer Stocks to Buy Right Now
Cancer remains the second leading cause of death globally, after heart disease.
Revna Biosciences and AstraZeneca Increase Access to Lung Cancer Treatment in Ghana
AstraZeneca PLC (NASDAQ:AZN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in.
11 Best GLP-1 and Weight Loss Stocks to Invest in
GLP-1 medicines are a type of prescription that mimics a natural hormone that regulates blood sugar and appetite.
AstraZeneca PLC (NASDAQ:AZN) Q2 2025 Earnings Call Transcript
AstraZeneca PLC (NASDAQ:AZN) Q2 2025 Earnings Call Transcript July 29, 2025AstraZeneca PLC reports earnings inline with expectations.
AstraZeneca Just Missed Estimates, but Here’s Why Bulls Aren’t Worried Yet
Parnassus Investments, an investment management firm, released its “Parnassus Value Equity Fund” second-quarter 2025 investor letter.
AstraZeneca (AZN) Bets Big on U.S. with $50 Billion Manufacturing Expansion
AstraZeneca PLC (NASDAQ:AZN) ranks among the stocks to benefit from an onshoring boom.
AstraZeneca PLC (AZN) Announced Positive Results for its Phase 3 Trial of Gefurulimab
AstraZeneca PLC (NASDAQ:AZN) is one of the Stocks With Huge Catalysts on the Horizon. On July 24, AstraZeneca PLC (NASDAQ:AZN) announced positive results for its global Phase...
10 Stocks With Huge Catalysts on the Horizon
The August 1 tariff deal is approaching; however, the market seems to have gotten used to the tariff headlines.
Hedge Fund Resource Center
